Medical Device Product Development

by EMMA International | Mar 30, 2020 | Uncategorized

Madison Wheeler, Manager of Technical Operations, discusses the characteristics of an efficient product development process for medical devices and how medical device product development should incorporate Quality, Regulatory, and Business needs in parallel.

EMMA International

EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting. We focus on quality, regulatory, and compliance services for the Medical Device, Combination Products, and Diagnostics industries.

More Resources

What the Eli Lilly $2.7 Billion AI Drug Discovery Deal Signals for Pharma in 2026

A recent $2.7 billion agreement between Eli Lilly and an artificial intelligence-driven drug discovery company is ...

How to Respond to an FDA Warning Letter

This whitepaper outlines a structured approach to responding to FDA Warning Letters, with a focus on root cause ...

Is FDA Increasing Focus on Change Control in 2026? Why Poorly Managed Changes Are Driving Inspection Findings

The U.S. Food and Drug Administration is placing increased scrutiny on change control systems across ...

No results found.

See All Resources

Medical Device Product Development

EMMA International

More Resources

What the Eli Lilly $2.7 Billion AI Drug Discovery Deal Signals for Pharma in 2026

How to Respond to an FDA Warning Letter

Is FDA Increasing Focus on Change Control in 2026? Why Poorly Managed Changes Are Driving Inspection Findings

From strategy to execution, EMMA delivers turnkey solutions with global expertise across every initiative.

Thank you for subscribing!

Pin It on Pinterest